China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China
· Delayed Price · Currency is CNY 26.55
-0.05 (-0.19%)
Apr 30, 2025, 3:04 PM CST
SHE:300294 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 384.45 | 396.99 | 237.47 | 432.2 | 344.53 | 260.06 | Upgrade
|
| Depreciation & Amortization | 100.87 | 100.87 | 98.57 | 97.03 | 99.35 | 81.34 | Upgrade
|
| Other Amortization | 16.09 | 16.09 | 15.39 | 13.74 | 13.63 | 13.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.61 | 0.61 | -1.3 | -0.07 | 0.87 | 1.58 | Upgrade
|
| Asset Writedown & Restructuring Costs | 83.8 | 83.8 | 326.72 | 53.65 | 80.57 | 0.27 | Upgrade
|
| Loss (Gain) From Sale of Investments | -78.64 | -78.64 | -99.75 | -43.84 | -43.11 | -10.14 | Upgrade
|
| Provision & Write-off of Bad Debts | 8.79 | 8.79 | 2.37 | 2.8 | 0.05 | -9.29 | Upgrade
|
| Other Operating Activities | -156.98 | -3.53 | 14.46 | 13.92 | 31.26 | 38.39 | Upgrade
|
| Change in Accounts Receivable | -211.49 | -211.49 | 40.02 | -11.73 | 799.83 | 390.43 | Upgrade
|
| Change in Inventory | -120.06 | -120.06 | 107.01 | 1.28 | 11.77 | -68.54 | Upgrade
|
| Change in Accounts Payable | 116.59 | 116.59 | -92.32 | 56.24 | 4.14 | 15.9 | Upgrade
|
| Change in Unearned Revenue | -4.01 | -4.01 | -3.57 | -4.13 | -1.46 | - | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 3.28 | 11.59 | - | Upgrade
|
| Operating Cash Flow | 133.79 | 299.78 | 641.73 | 596.44 | 1,345 | 718.58 | Upgrade
|
| Operating Cash Flow Growth | -75.36% | -53.29% | 7.59% | -55.67% | 87.23% | - | Upgrade
|
| Capital Expenditures | -296.09 | -197.79 | -87.5 | -138.41 | -68.12 | -142.51 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.73 | 1.82 | 3.26 | 0.33 | 4.41 | 1.66 | Upgrade
|
| Cash Acquisitions | -1,778 | -1,778 | - | - | - | - | Upgrade
|
| Divestitures | 130.18 | 239.61 | 269 | - | - | - | Upgrade
|
| Investment in Securities | 735.5 | 975.51 | -248.85 | -500 | -2,505 | 7.02 | Upgrade
|
| Other Investing Activities | 119.95 | 111.26 | 78.33 | 77.86 | 32.4 | 5.5 | Upgrade
|
| Investing Cash Flow | -1,088 | -647.53 | 14.25 | -560.22 | -2,536 | -128.34 | Upgrade
|
| Long-Term Debt Issued | - | - | 22.15 | - | 251.85 | 820 | Upgrade
|
| Long-Term Debt Repaid | - | -76.3 | -24.98 | -3.82 | -563.55 | -1,113 | Upgrade
|
| Net Debt Issued (Repaid) | -76.3 | -76.3 | -2.83 | -3.82 | -311.7 | -292.56 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 2,400 | - | Upgrade
|
| Common Dividends Paid | -232.41 | -232.41 | -100.85 | -83.19 | -46.03 | -88.81 | Upgrade
|
| Other Financing Activities | 3.59 | 5.24 | -132.97 | 2 | -9.64 | -9.09 | Upgrade
|
| Financing Cash Flow | -305.12 | -303.47 | -236.65 | -85.01 | 2,032 | -390.46 | Upgrade
|
| Net Cash Flow | -1,259 | -651.23 | 419.33 | -48.79 | 841.39 | 199.78 | Upgrade
|
| Free Cash Flow | -162.3 | 101.99 | 554.23 | 458.03 | 1,277 | 576.07 | Upgrade
|
| Free Cash Flow Growth | - | -81.60% | 21.00% | -64.14% | 121.72% | - | Upgrade
|
| Free Cash Flow Margin | -8.91% | 5.88% | 20.90% | 16.60% | 48.19% | 22.92% | Upgrade
|
| Free Cash Flow Per Share | -0.32 | 0.20 | 1.10 | 0.91 | 2.93 | 1.35 | Upgrade
|
| Cash Income Tax Paid | 178.64 | 167.06 | 250.39 | 227.94 | 192.85 | 190.04 | Upgrade
|
| Levered Free Cash Flow | -367.01 | 16.4 | 376.4 | 354.85 | 1,141 | 449.92 | Upgrade
|
| Unlevered Free Cash Flow | -366.55 | 16.82 | 376.68 | 355.24 | 1,148 | 463.33 | Upgrade
|
| Change in Net Working Capital | 431.91 | 166.18 | -19.35 | -65.91 | -843.82 | -304.88 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.